BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Octapharma AG 

Seidenstraße 2

Lachen    CH-8853  Switzerland
Phone: 41-55-451-2121 Fax: 41-55-451-2110


SEARCH JOBS




Industry
Services






 Company News
Octapharma AG Phase 2/3 Trial For The Targeted Treatment Of Relapsing Multiple Sclerosis Enrols First Patients 12/18/2013 9:32:30 AM    More...
Octapharma AG Enters Into Agreement With Pfizer Inc. (PFE) For The Future Commercialization And Marketing In The U.S. Of An Investigational Intravenous Therapy For The Urgent Reversal Of An Oral Anticoagulant 12/11/2013 9:48:06 AM    More...
Octapharma AG Leading Corporate Sponsor of Save One Life 5/30/2013 10:35:28 AM    More...
FDA Approves Octaplas® Expanding Octapharma USA, Inc.'s Transfusion Medicine Therapies 1/18/2013 8:02:53 AM    More...
Octapharma AG Sponsors Educational Programs, Presents Research at the 64th Annual NHF Meeting in Orlando 11/7/2012 10:05:22 AM    More...
Octapharma AG Opens $32 Million Recombinant Research Facility in Heidelberg 9/28/2012 7:11:45 AM    More...
Octapharma AG Hosts Symposium at World Federation of Hemophilia World Congress on "Personalizing the Inhibitor Treatment and Prevention" in Hemophilia A 7/25/2012 10:15:36 AM    More...
Octapharma AG Hosts Symposium at WFH World Congress on Meeting the Challenges of Von Willebrand Disease (VWD) Diagnosis and Treatment 7/25/2012 9:35:44 AM    More...
Octapharma AG Releases 2011 Annual Report 4/3/2012 10:19:14 AM    More...
Octapharma AG Reports Octagam® 5% and Octagam® 10% Global Sales Totaled 1.7 Million Grams Through October With No Thromboembolic Events 11/15/2011 12:11:25 PM    More...
1234